6.
Zuin M, Rigatelli G, Zuliani G, Roncon L
. Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19. Lancet. 2021; 398(10308):1303-1304.
PMC: 8497034.
DOI: 10.1016/S0140-6736(21)01859-6.
View
7.
Wang M, Yu X, Zhou L, Si H, Hui J, Hou D
. COVID-19 and liver dysfunction: What nutritionists need to know. World J Gastroenterol. 2022; 28(15):1526-1535.
PMC: 9048466.
DOI: 10.3748/wjg.v28.i15.1526.
View
8.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S
. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020; 180(7):934-943.
PMC: 7070509.
DOI: 10.1001/jamainternmed.2020.0994.
View
9.
Wu T, Zuo Z, Kang S, Jiang L, Luo X, Xia Z
. Multi-organ Dysfunction in Patients with COVID-19: A Systematic Review and Meta-analysis. Aging Dis. 2020; 11(4):874-894.
PMC: 7390520.
DOI: 10.14336/AD.2020.0520.
View
10.
Li Y, Zhao K, Wei H, Chen W, Wang W, Jia L
. Dynamic relationship between D-dimer and COVID-19 severity. Br J Haematol. 2020; 190(1):e24-e27.
PMC: 7276819.
DOI: 10.1111/bjh.16811.
View
11.
Gracia-Ramos A, Jaquez-Quintana J, Contreras-Omana R, Auron M
. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol. 2021; 27(26):3951-3970.
PMC: 8311530.
DOI: 10.3748/wjg.v27.i26.3951.
View
12.
Sahu B, Kampa R, Padhi A, Panda A
. C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020; 509:91-94.
PMC: 7274122.
DOI: 10.1016/j.cca.2020.06.013.
View
13.
Mangano C, Oliva B
. Relationship between lymphocyte subsets values and C-reactive protein in COVID-19 patients. Cytometry A. 2021; 99(5):462-465.
PMC: 8013919.
DOI: 10.1002/cyto.a.24327.
View
14.
Smith D, Duval A, Grant R, Abbas M, Harbarth S, Opatowski L
. Predicting consequences of COVID-19 control measure de-escalation on nosocomial transmission and mortality: a modelling study in a French rehabilitation hospital. J Hosp Infect. 2024; 147:47-55.
DOI: 10.1016/j.jhin.2024.02.020.
View
15.
Rossi G, Salmanton-Garcia J, Cattaneo C, Marchesi F, Davila-Valls J, Martin-Perez S
. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings. Int J Infect Dis. 2023; 137:98-110.
DOI: 10.1016/j.ijid.2023.10.013.
View
16.
Hawerkamp H, Dyer A, Patil N, McElheron M, ODowd N, ODoherty L
. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19. Front Immunol. 2023; 14:1170012.
PMC: 10101230.
DOI: 10.3389/fimmu.2023.1170012.
View
17.
Paliogiannis P, Mangoni A, Dettori P, Nasrallah G, Pintus G, Zinellu A
. D-Dimer Concentrations and COVID-19 Severity: A Systematic Review and Meta-Analysis. Front Public Health. 2020; 8:432.
PMC: 7438945.
DOI: 10.3389/fpubh.2020.00432.
View
18.
OLeary A, Wattengel B, Carter M, Drye A, Mergenhagen K
. Risk factors associated with mortality in hospitalized patients with laboratory confirmed SARS-CoV-2 infection during the period of omicron (B.1.1.529) variant predominance. Am J Infect Control. 2022; 51(6):603-606.
PMC: 9444305.
DOI: 10.1016/j.ajic.2022.08.033.
View
19.
Raman N, Kv P, Ashta K, Vardhan V, Thareja S, J M
. Ferritin and Hemoglobin as Predictors of Fatal Outcome in COVID-19: Two Sides of the Same Coin. J Assoc Physicians India. 2021; 69(8):11-12.
View
20.
Liang W, Liang H, Ou L, Chen B, Chen A, Li C
. Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020; 180(8):1081-1089.
PMC: 7218676.
DOI: 10.1001/jamainternmed.2020.2033.
View